Exane Derivatives’s Cintas CTAS Stock Holding History

Exane Derivatives’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.12K	Hold	12	–	–	﹤0.01%	496
2022 Q1	$1.28K	Hold	12	–	–	﹤0.01%	787
2021 Q4	$1.33K	Hold	12	–	–	﹤0.01%	687
2021 Q3	$1.14K	Hold	12	–	–	﹤0.01%	846
2021 Q2	$1.14K	Hold	12	–	–	﹤0.01%	859
2021 Q1	$1.02K	Hold	12	–	–	﹤0.01%	734
2020 Q4	$1.06K	Hold	12	–	–	﹤0.01%	672
2020 Q3	$998	Hold	12	–	–	﹤0.01%	619
2020 Q2	$799	Hold	12	–	–	﹤0.01%	566
2020 Q1	$520	Hold	12	–	–	﹤0.01%	593
2019 Q4	$854	Sell	12 -16	-57%	-$1.05K	﹤0.01%	555
2019 Q3	$1.88K	Hold	28	–	–	﹤0.01%	497
2019 Q2	$1.66K	Hold	28	–	–	﹤0.01%	521
2019 Q1	$1.41K	Sell	28 -4	-13%	-$194	﹤0.01%	480
2018 Q4	$1.34K	Sell	32 -24	-43%	-$1.07K	﹤0.01%	554
2018 Q3	$2.76K	Buy	+56	New	+$2.89K	﹤0.01%	479
2017 Q3	–	Sell	-4	Closed	-$126	–	588
2017 Q2	$126	Hold	4	–	–	﹤0.01%	560
2017 Q1	$127	Hold	4	–	–	﹤0.01%	483
2016 Q4	$116	Hold	4	–	–	﹤0.01%	533
2016 Q3	$113	Hold	4	–	–	﹤0.01%	530
2016 Q2	$98	Sell	4 -628,736	-100%	-$14.5M	﹤0.01%	469
2016 Q1	$14.1M	Sell	628,740 -136,780	-18%	-$2.93M	1.87%	18
2015 Q4	$17.4M	Sell	765,520 -94,468	-11%	-$2.15M	2.39%	15
2015 Q3	$18.4M	Buy	+859,988	New	+$18.5M	2.33%	12

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Exane Derivatives's CTAS Position: Q2 2022 in Review

Exane Derivatives held its Cintas (CTAS) position steady in Q2 2022 at 12 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #496.

Exane Derivatives first reported a position in CTAS in Q3 2015 and has held it in 24 quarters since. The position peaked at $18.4M in Q3 2015. 898 funds tracked by Wall St. Rank hold CTAS as of Q2 2022.

Exane Derivatives held 12 shares of Cintas worth $1.12K as of Q2 2022.
Exane Derivatives left its Cintas share count unchanged in Q2 2022.
Cintas made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #496 holding.
Exane Derivatives first reported a position in Cintas in Q3 2015 and has held it in 24 quarters since.
Exane Derivatives's Cintas position peaked at $18.4M in Q3 2015.
898 funds tracked by Wall St. Rank held Cintas as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.